The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
Farhad Imam(Gates (United States)), Chengran Yang(Washington University in St. Louis), Timothy J. Hohman(Vanderbilt University Medical Center), Alexa Pichet Binette(Lund University), Agustı́n Ruiz(The University of Texas at San Antonio Health Science Center), Laura Winchester(University of Oxford), Amelia Farinas(Neurosciences Institute), Adam L. Boxer(University of California, San Francisco), Oliver Robinson(Imperial College London), Allan I. Levey(Emory University), Inga Liepelt-Scarfone(German Center for Neurodegenerative Diseases), Andrew J. Saykin(Indiana University School of Medicine), Tony Wyss‐Coray(Neurosciences Institute), Pieter Jelle Visser, Mika Kivimäki(University of Helsinki), Betty M. Tijms(Amsterdam Neuroscience), Chad Slawson(University of Kansas Medical Center), Varsha Krish(Gates (United States)), Roxanna Korologou‐Linden(MRC Unit for Lifelong Health and Ageing), Carlos Cruchaga(Washington University in St. Louis), Rowan Saloner(University of California, San Francisco), Erik C. B. Johnson(Emory University), Jeffrey L. Dage(Indiana University School of Medicine), Jeffrey D. Rothstein(Johns Hopkins University), Niklas Mattsson(Lund University), Eric M. Reiman(Banner Alzheimer’s Institute), Muhammad Ali(Washington University in St. Louis), Oskar Hansson(Lund University), Hamilton Oh(Allen Institute for Brain Science), Martin Bringmann(Max Planck Institute of Molecular Plant Physiology), Federica Anastasi(Pasqual Maragall Foundation), Jeffrey M. Burns(University of Kansas), Keenan A. Walker(National Institute on Aging), Caitlin A. Finney(The University of Sydney), Artur Shvetcov(The University of Sydney), Gamal Abdel-Azim(Johnson & Johnson (United States)), Natàlia Vilor‐Tejedor(Universitat Pompeu Fabra), Maarten Timmers, Jacob W. Vogel(University of Pennsylvania), Marc Suárez‐Calvet(Pasqual Maragall Foundation), Mark Frasier(Michael J. Fox Foundation), Kwangsik Nho(Regenstrief Institute), Lina Lu(Lund University), Lefkos Middleton(MRC Unit for Lifelong Health and Ageing), Bart Smets, David A. Bennett, Ronald Petersen(Mayo Clinic), Lijun An(Lund University), Luigi Ferrucci(National Institute on Aging), Fernando G. Vieira(Amyotrophic Lateral Sclerosis Therapy Development Institute)
Cited by 85
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Microglia states and nomenclature: A field at its crossroads
|Neuron|2022|1.8k